
Trending News Today: Controversy Surrounds Trump Pick for HHS Secretary
Top news of the day from across the healthcare landscape.
The state of California recently withdrew their request to sell health insurance plans to undocumented immigrants,
Several senators who are criticizing Rep Tom Price (R-GA), Trump’s pick to run the Department of Health and Human Services (HHS), have substantial holdings in pharmaceutical companies. Price is being questioned about the ethics of having stock holdings in certain companies that have been affected by legislation he has written or voted for. However, at least 6 members involved with the confirmation process also have holdings in Merck, Gilead, and other pharmaceutical companies, according to
Price told the Senate Health Committee that if he is confirmed as Trump’s pick for HHS secretary, he will protect Americans, according to the
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.














































































































































































































